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Abstract 23 
Tight junction and epithelial barrier disruption is a common trait of many gastrointestinal pathologies, 24 
including chemotherapy-induced gut toxicity. Currently, there are no validated in vitro models suitable 25 
for the study of chemotherapy-induced mucosal damage that allow paralleled functional and structural 26 
analyses of tight junction integrity. We therefore aimed to determine if a transparent, polyester 27 
membrane insert supports a polarised T84 monolayer with the phenotypically normal tight junctions. 28 
T84 cells (passage 5-15) were seeded into either 0.6 cm2, 0.4 m pore mixed cellulose transwell 29 
hanging inserts, or 1.12 cm2 0.4 m pore polyester transwell inserts at varying densities. 30 
Transepithelial electrical resistance (TEER) was measured daily to assess barrier formation. 31 
Immunofluoresence for key tight junction proteins (occludin, zonular occludens-1, claudin-1) and 32 
transmission electron microscopy were performed to assess tight junction integrity, organelle 33 
distribution and polarity. RT-PCR was performed to determine expression of TLR4. Liquid 34 
chromatography was also conducted to assess SN38 degradation in this model. Polyester membrane 35 
inserts support a polarised T84 phenotype with functional tight junctions in vitro. Transmission 36 
electron microscopy indicated polarity, with apico-laterally located tight junctions. 37 
Immunofluorescence showed membranous staining for all tight junction proteins. No internalisation 38 
was evident. T84 cells expressed TLR4, although this was significantly lower than levels seen in HT29 39 
cells (p=0.0377). SN38 underwent more rapid degradation in the presence of cells (-76.041.86%) 40 
compared to blank membrane (-48.394.01%), indicating metabolic processes. Polyester membrane 41 
inserts provide a novel platform for paralleled functional and structural analysis of tight junction 42 
integrity in T84 monolayers. T84 cells exhibit the unique ability to metabolise SN38 as well as 43 
expressing TLR4, making this an excellent platform to study clinically relevant therapeutic 44 
interventions for SN38-induced mucosal damage by targeting TLR4.  45 
 46 
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Introduction  49 
The intestinal epithelium has two important and distinctly different roles within the gastrointestinal 50 
tract (GIT). It mediates the complex absorption of nutrients from the intestinal lumen, and 51 
simultaneously represents a barrier separating the internal milieu from the outside environment in both 52 
an immunologic and metabolic sense (1). In the gut, the luminal surface comes into direct contact with 53 
the highest concentrations of bacteria (2), antigens and a host of potentially toxic compounds (3). 54 
Consequently, the paradoxical functions of the intestinal barrier are critical in maintaining 55 
gastrointestinal health and homeostasis (4).  56 
Tight junctions provide a paracellular barrier that is selectively permeable to ions and macromolecules. 57 
The molecular characteristics and functional properties of tight junctions are subject to modification by 58 
a variety of cues, both physiological and pathological, highlighting the highly dynamic nature of these 59 
structures (5). Consequently, tight junction disruption often leads to the development of a leaky gut (6); 60 
a hallmark feature of compromised mucosal barrier function and many pathological states (7). A 61 
thorough understanding of tight junction regulation, signaling and modification is therefore critical to 62 
determine how they may contribute to disease progression. This holds particularly true for 63 
chemotherapy-induced gut toxicity, which is characterised clinically by increased intestinal 64 
permeability (8) and tight junction defects (9, 10). Despite molecular disruption to tight junctions being 65 
reported, the underlying mechanisms are unclear and difficult to identify in full physiological systems.  66 
Chemotherapy treatment has long been recognised to induce a leaky gut, with recent research 67 
suggesting tight junction disruption may contribute to the development of clinically diagnosed 68 
diarrhoea through altered leak-flux mechanisms (11). Irinotecan is a chemotherapeutic drug associated 69 
with exceptionally high levels of intestinal toxicity. It serves as the water-soluble precursor of the 70 
lipophilic metabolite, SN38, which is formed by carboxylesterase-mediated cleavage of the carbamate 71 
bond between the camptothecin moiety and the dipiperdino side chain (12). SN38 is approximately 72 
1000 times as potent as irinotecan as an inhibitor of topoisomerase I and its unique hepatobiliary 73 
metabolism is responsible for the high levels of intestinal toxicity (13). SN38 is glucoronidated to 74 
SN38 glucuronide (SN38G) and detoxified in the liver via conjugation by the uridine-diphospho-75 
glucuronosyl transferase (UGT1A) family, which releases SN38G into the intestines for elimination 76 
(14). However, in the intestinal lumen, bacterial -glucoronidases are able to regenerate SN38 from 77 
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SN38G (15). This second pass metabolism is key to the dose-limiting, and clinically diagnosed, 78 
diarrhoea associated with irinotecan treatment.  79 
Although our understanding of irinotecan and SN38-induced gastrointestinal toxicity is improving, 80 
many studies’ mechanistic data are limited to due the difficulties in accessing the GIT. In vitro models 81 
therefore offer an appealing alternative of studying GI-related pathologies. Epithelial cell lines derived 82 
from the intestine can be cultured as monolayers to mimic the intestinal epithelium and provide insight 83 
into the physiological characteristics of tight junctions and epithelial barrier function (4). The human 84 
colonic epithelial cell line, T84, derived from a colonic carcinoma, is widely used in vitro to assess 85 
intestinal barrier function and tight junction integrity (16, 17).  86 
T84 cells are typically cultured in vitro using a mixed-cellulose membrane, semi-permeable transport 87 
system (Figure 1), which readily allows assessment of barrier function. However, these opaque mixed-88 
cellulose membranes, although considered gold-standard, limit downstream imaging techniques such as 89 
light or confocal microscopy, critical for a thorough understanding of tight junction signaling and 90 
integrity. We therefore aimed to determine if a transparent, polyester membrane insert supports a 91 
polarised T84 monolayer with phenotypically normal tight junctions. The long-term goal is for our 92 
model to be used for interrogation of complex gastrointestinal physiology under normal and challenged 93 
states. If successful, this model will be used to study mechanisms of chemotherapy (specifically 94 
irinotecan)-induced mucosal damage in a simple, high-throughput manner. Additionally, this novel 95 
platform could be used to assess the efficacy of anti-mucotoxic agents for both preclinical and clinical 96 
translation.  97 
  98 
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Materials and Methods   99 
Cell Culture  100 
Cryopreserved T84 cells (passage 5-15) derived from a human colorectal carcinoma were obtained 101 
from Culture Collections (Porton Down, UK; 88021101). HT29 cells (passage 5-15), derived from a 102 
human colorectal carcinoma with an epithelial phenotype, were kindly provided by Dr J Hardingham 103 
(Queen Elizabeth Hospital, South Australia). MCF-7 cells (passage 1-6), derived from a human breast 104 
carcinoma were also a kind gift from Professor M Brown (Royal Adelaide Hospital, South Australia). 105 
All cells lines retained their original morphology and growth characteristics over the range of passages 106 
used (data not shown).  107 
Cells were thawed in a 37oC water bath and maintained in a 75 cm2 or 150 cm2 sterile cell culture flask 108 
(Corning Life Sciences, MA, USA) at 37oC with 5% CO2. T84 and HT29 cell culture media was 109 
Dulbecco’s Modified Eagle Medium/Ham’s F-12 Nutrient Mixture containing 15 mM HEPES, L-110 
glutamine and sodium bicarbonate (DMEM/F-12; Sigma-Aldrich, Castle Hill, NSW, Australia; D8437) 111 
supplemented with 1% penicillin/gentamicin+fungizone, 10% foetal bovine serum and 1mM l-112 
glutamine (complete DMEM). MCF-7 cells were maintained in RMPI media supplemented with 2 mM 113 
L-glutamine and 10% FBS.  Experimental cell cultures were grown in sterile, multi-well tissue culture 114 
plates under identical growth conditions. Cell lines were routinely passaged when culture monolayers 115 
reached approximately 80% confluence at subculture ratios between 1:3 and 1:6 in fresh growth 116 
medium. Cells were detached by aspirating growth medium, washing with 1X phosphate buffered 117 
saline (PBS; pH 7.4) and incubating with 3 ml of trypsin-EDTA for 10 min at 37oC (0.05% trypsin, 118 
0.53 mM EDTA; Invitrogen, Mulgrave, VIC, Australia). The reaction was then quenched by the 119 
addition of growth medium. Cells were centrifuged at 300 g for 5 min, supernatant removed and cells 120 
resuspended in fresh, complete DMEM. Cell count were conducted using an automated cell counter 121 
(BioRad, NSA, Australia) and were seeded into either 0.6 cm2, 0.4 m pore mixed cellulose transwell 122 
hanging inserts (Invitrogen, VIC, Australia; PIHA01250), or 1.12 cm2 0.4 m pore polyester transwell 123 
inserts (Corning Life Sciences, MA, USA; CLS3801). T84 cells were seeded at the following densities: 124 
50,000; 100,000; 200,000 and 400,000 cells/cm2 into the apical chamber. Cell culture media in both the 125 
apical and basolateral chambers was changed every 48 h. Transepithelial electrical resistance (TEER) 126 
was measured daily using am EVOM2 epithelial volt-ohm-meter with chopstick electrodes (World 127 
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Precision Instruments, Sarasota, FL, USA) for 1 week during the growth period and area adjusted for 128 
analysis using the following formula; TEER monolayer (/cm2) = [raw TEER () – TEER blank 129 
()]/area of membrane (cm2). All experiments were performed in triplicate and repeated twice. 130 
Transmission Electron Microscopy  131 
After determining optimal cell density (100,000 cells/cm2), cells were seeded into both 0.6 cm2, 0.4 m 132 
pore mixed cellulose transwell hanging inserts (Invitrogen, VIC, Australia; PIHA01250), or 1.12 cm2 133 
0.4 m pore polyester transwell inserts (Corning Life Sciences, MA, USA; CLS3801) at a density of 134 
100,000 cells/cm2. Cell culture media was changed every 48 hour. TEER was measured daily from day 135 
3 using an EVOM2 epithelial volt-ohm-meter. Once high, stable TEER was achieved monolayers were 136 
fixed overnight in 4% paraformaldehyde/1.25% glutaraldehyde (electron microscopy grade) in 1X PBS 137 
(4% sucrose; pH 7.2). Monolayers were washed with 1x PBS + 4% sucrose (v/v) before being post-138 
fixed in 2% osmium tetroxide (w/v) for 1 hour. Monolayers were dehydrated through graded ethanols, 139 
removed from the transwell support system and mounted in resin before being polymerised at 70oC for 140 
24 hours.  80µm thick sections were cut on a Leica Ultracut S ultramicrotome using a diamond knife. 141 
Sections were picked up on 200mesh copper/palladium grids and stained with uranyl acetate and Lead 142 
Citrate. Grids were then visualised using the Philips CM200 transmission electron microscope (TEM). 143 
Monolayers were assessed for the presence of tight junctions, organelle distribution, polarity and 144 
monolayer formation. Monolayers with TEER values over 1000 /cm2 were used in all experiments.  145 
Immunofluorescence  146 
A secondary aim of this study was to determine if the polyester membrane transwell support systems 147 
support immunofluorescence and confocal imaging. T84 cells were seeded into 1.12 cm2 0.4 m pore 148 
polyester transwell inserts at a density of 100,000 cells/cm2. Once T84 monolayers had developed 149 
stable TEER values >1000 /cm2 cell culture media was aspirated and cells washed with ice-cold 1X 150 
PBS pH 7.4. A fixing solution (1:1 v/v acetone/methanol stored at -20oC) was applied to the apical 151 
chamber (500 l) for 15 min. Cells were rinsed with 1X PBS and permeabilised using 0.1% (v/v) 152 
Triton X-100/PBS for 3 min. After 2 x 5 min washes in 1X PBS, cells were blocked overnight in 3% 153 
(w/v) bovine serum albumin (BSA)/PBS at 4oC (Sigma-Aldrich, NSW, Australia; 9048-46-8). The 154 
blocking solution was aspirated and 200 l of primary antibody was applied to the apical chamber 155 
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(mouse mAb occludin, Invitrogen 33-1500, 5 g/ml; rabbit pAb ZO-1, Invitrogen 61-7300, 2.5 g/ml; 156 
rabbit pAb claudin-1, Abcam ab15098, 2 g/ml). All primary antibodies were diluted in 1% (w/v) 157 
BSA/PBS and incubated for 1 h at room temperature. The primary antibody was then aspirated, and 158 
cells washed in 1X PBS+0.05% Tween (4 x 5 min). 200 l of fluorescent-conjugated secondary 159 
antibody (anti-mouse 488; anti-rabbit 568 Alexa Fluor®; Invitrogen, VIC, Australia) was added to the 160 
apical chamber at 100 g/ml. All secondary antibodies were diluted in 1% (w/v) BSA/PBS and 161 
incubated for 1 hour at room temperature. For nuclear staining, cells were incubated with 1 g/ml 4’,6-162 
diamidino-2-phenylidole (DAPI) for 10 min at room temperature. Cells were washed in 1X PBS+0.05 163 
Tween for 4 x 5 min before the membranes were removed from the inserts and mounted onto glass 164 
microscope slides using FluoroshieldTM (Sigma-Aldrich, NSW, Australia; #F6182). Cells were 165 
visualised using the SP5 Spectral Scanning Confocal Microscope (Leica, Wetzlar, Germany). Negative 166 
controls had the primary antibody omitted.  167 
Liquid chromatography–mass spectrometry 168 
The long-term goal is for this in vitro model to be used to assess the mechanisms involved in SN38-169 
induced mucosal damage to identify potential targets for the development of interventions. It is well 170 
recognised that SN38, the active metabolite of irinotecan, is a basic compound and typically unstable in 171 
many physiological solutions. It is therefore important to characterise the degradation and potential 172 
metabolism of SN38 in this model prior to implementing its usage. As per section 2.3, cells were 173 
seeded in triplicate into polyester membrane transwell support systems and TEER monitored daily. 174 
When a stable TEER >1000 /cm2 was achieved, cells were treated with 5 M SN38 in the apical and 175 
basolateral chambers. To determine the natural degradation of SN38, transwell systems containing no 176 
T84 cells were filled with SN38 supplemented cell culture media (5 M). Each transwell system with 177 
T84 cells and without T84 cells (negative control) was subject to identical conditions. 25 l from the 178 
apical and basolateral chambers was collected at 0 h, 1 h, 3 h, 6 h, 24 h and 48 h. Apical and basolateral 179 
samples were combined (50 l) to produce a single sample per time point. All experiments were 180 
performed in triplicate and repeated.  181 
Sample Preparation 182 
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50 l of sampled cell culture media was added to 150 l of ice-cold acetonitrile with 0.1% formic acid 183 
(containing 20 ng/ml of IS). Samples were vortexed for 10 s and centrifuged at 13,300 rpm for 10 min 184 
at room temperature. A 180 l aliquot of the supernatant was transferred to a clean microtube and 10 l 185 
samples were analysed in triplicate using liquid chromatography–mass spectrometry (ABSCIEX 186 
TripleTOFTM  5600 LC/MS/MS).  187 
Chromatographic Conditions 188 
The ABSCIEX TripleTOFTM  5600 LC/MS/MS was used to perform liquid chromatography–mass 189 
spectrometry analysis. Chromagraphic separation was achieved by using a Kinetex C18 (2.6 l, 50 mm 190 
x 3.0 mm) analytical column (Phenomenex, NSW, Australia; #00A-4633-AN). The mobile phase A 191 
was 5% acetonitele, 95% water, 0.1% formic acid. Mobile phase B was 95% acetonitele, 95% water, 192 
0.1% formic acid with a 0.2 ml/min flow rate. The gradient system commenced with 90/10 mobile 193 
phase A/B for 30 s, whilst mobile phase A was gradually decreased to 0% by 2 min. This was 194 
maintained for 3 min before returning to initial conditions. The retention times for SN38 and 195 
camptothecin (CPT; internal standard) were 2.1 min and 2.16 min, respectively.  196 
Standard Curve Generation  197 
A working standard solution of 1 g/ml was diluted accordingly to achieve: 500 ng/ml, 375 ng/ml, 250 198 
ng/ml, 125 ng/ml, 50 ng/ml, 25 ng/ml, 5 ng/ml and 2.5 ng/ml of SN38. 10 l of each solution were 199 
spiked into 40 l of blank plasma. Final SN38 concentrations were 100 ng/ml, 75 ng/ml, 25 ng/ml, 5 200 
ng/ml, 1 ng/ml and 0.5 ng/ml. The lower limit of detection was 0.1 ng/ml and lower limit of 201 
quantification was 0.5 ng/ml. SN38 concentration was determined by interpolation from the calibration 202 
curve and presented as molarity and percentage decrease from baseline.   203 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Analysis of TLR4    204 
Toll-like receptor 4 (TLR4) is an emerging mediator of irinotecan-induced gut toxicity and a promising 205 
target for the development of potential interventions. In order for this platform to be used in the 206 
development of TLR4-targted interventions, it is imperative that TLR4 expression be confirmed. TLR4 207 
expression in HT29 and Caco-2 cells was used as a positive control.  208 
RNA Isolation 209 
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To determine TLR4 mRNA expression, T84 (p7), Caco-2 (p46) and HT29 (p5) cells were grown to 210 
confluence in 90mm culture dishes. Total RNA extraction was performed on each cell line using the 211 
NucleoSpin RNA Isolation Kit as per manufacturer’s instructions (NucleoSpin RNA Isolation Kit, 212 
Macherey-Nagel, Düren, Germany; #740955). Once eluted, RNA was stored at -80 oC. Total RNA was 213 
quantified using the BioTek Synergy™ Mx Microplate Reader (BioTek, Vermont, USA), TAKE3 plate 214 
and Gen5 (version 2.00.18) software. RNA purity was also determined using the the BioTek Synergy™ 215 
Mx Microplate Reader (BioTek, Vermont, USA), TAKE3 plate and Gen5 (version 2.00.18) software. 216 
RNA integrity was assessed at the Adelaide Microarray Facility (South Australia Health and Medical 217 
Research Institute) using the Agilent 2100 Bioanalyser RNA 600 Nano Chip (Series II) kit.  218 
Reverse Transcription and RT-PCR 219 
1 g of total RNA was reverse transcribed using the iScriptTM cDNA Synthesis Kit (BioRad, NSA, 220 
Australia; #1708890) as per manufacturers instructions. RT-PCR was performed using the Rotor-Gene 221 
3000 (Corbett Research, NSW, Australia). Amplification mixes contained 2 l of cDNA sample (100 222 
ng/l), 5 l of SYBR green fluorescence dye, 2 l of RNase-free water and 0.5 l of each forward and 223 
reverse primers, prediluted to 50 pmol/l, to make a total volume of 10 l. Thermal cycling conditions 224 
included a denaturing step at 95 oC for 15 min, followed by 40 cycles of denaturation at 95oC for 15s, 225 
annealing at 60 oC for 15s and extension at 72 oC for 15 s. All samples were run in triplicate. Primer 226 
efficiency was evaluated using standard curves and experimental threshold (Ct) values were calculated 227 
by the Rotor Gene 6 programme. CT values were used to quantify relative mRNA expression of TLR4 228 
in T84 cells and human colonic tissue using the CT method, relative where TLR4 expression = 229 
2−[𝐶𝑇(𝑡𝑎𝑟𝑔𝑒𝑡)−𝐶𝑇(𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒). -actin was used as an internal housekeeping (reference) gene.  230 
Primer details are as follows: TLR4 primer sequence 5’-3’ F: TGA GCA GTC GTG CTG GTA TC 231 
(Tm3 54oC), R: CAG GGC TTT TCT GAG TCG TC (Tm3 54oC), NM_003266.3, 167 bp. -actin 232 
primer sequence 5’-3’ F: CTC TTC CAG CCT TCC TTC CT (Tm3 54oC), R: AGC ACT GTG TTG 233 
GCG TAC AG (Tm3 54oC), NM_001101.3, 116 bp. 234 
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 235 
Statistical analysis  236 
Data were compared using Prism version 7.0 (GraphPad® Software, San Diego, USA). A D’Agostino-237 
Pearson omnibus test was used to assess normality. When normality was confirmed, a paired t-test or 238 
two-way analysis of variance with appropriate post hoc testing were performed to identify statistical 239 
significance. In other cases, a Kruskall-Wallis test with Dunn’s multiple comparisons test and 240 
Bonferroni correction was performed. A p-value of ˂0.05 was considered significant. 241 
  242 
Table 2 Primer Sequences and Characteristics 
Gene Primer Sequence (5’-3’) mRNA Sequence  Amplicon Length Tm3 (oC) 
TLR4 F: TGA GCA GTC GTG CTG GTA TC 
R: CAG GGC TTT TCT GAG TCG TC 
 NM_003266.3 167 bp F: 54 
R: 54 
-actin F: CTC TTC CAG CCT TCC TTC CT 
R: AGC ACT GTG TTG GCG TAC AG 
NM_001101.3 116 bp F: 54 
R: 54 
* Designed by Primer3, analysed using NetPrimer software and synthesised by Geneworks Ltd.   
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Results 243 
Polyester membrane inserts support a polarised T84 phenotype with functional tight junctions in vitro  244 
T84 cells seeded at all density ranges, in both transwell support systems, achieved TEER values greater 245 
than 1000 /cm2 within seven days (Figure 2a, 2b). T84 cells seeded at 200,000 cells/cm2 had an 246 
elevated trajectory, whilst a seeding density of 50,000 cells/cm2 displayed delayed maturation and 247 
resistance development. Monolayers seeded at 100,000 cells/cm2 displayed consistent and controlled 248 
development of resistance. This trajectory is likely to facilitate optimal differentiation. When seeded at 249 
100,000 cells/cm2, T84 cells exhibited comparable resistance development characteristics in both 250 
transwell support systems, with no statistically significant differences observed (Figure 2c).  251 
TEM analysis confirmed T84 monolayers grown on polyester membranes displayed polarity, with 252 
basally-located nuclei and apical microvilli (Figure 3a). TEM analysis also showed intercellular 253 
junctional complexes (tight junction, intermediate junction and desmosome) at the apico-lateral border 254 
(9) of cells (Figure 3b, 3c). The presence of molecularly intact tight junctions in polyester membrane 255 
support system was confirmed by immunofluorescence for three major tight junction proteins: zonular 256 
occludens-1 (ZO-1), occludin and claudin-1 (Figure 4a-c). No internalization or cytoplasmic 257 
redistribution was evident. These results also highlight the imaging potential of this support system, 258 
facilitating both light and confocal microscopy techniques. No fluorescence was detected on any 259 
membrane that had the primary antibody omitted (data not shown).  260 
SN38 stability in the transwell support system   261 
SN38 underwent rapid degradation in cell culture media alone (negative control; -T84 monolayer), 262 
with a 48.394.01% decrease from baseline by 1 h (Figure 5a, 5b). This decline was more pronounced 263 
in transwell systems with T84 monolayers (-76.041.86%) indicating metabolic processes (*p<0.0001; 264 
p=0.0126). SN38 concentration plateaued between 1 h and 24 h, although a small increase was 265 
observed at 48 h in the presence of T84 monolayers suggesting possible efflux mechanisms.  266 
T84 cells express TLR4 267 
RNA integrity numbers (RIN) were assigned to each sample using the Agilent Bioanalyser. Caco-2 cell 268 
yielded the highest RIN score (RIN: 8.90). HT29 and T84 cells had RIN scores of 8.00 and 7.90 269 
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respectively. RNA A260/280 ratios for Caco-2, HT29 and T84 cells were 2.098, 2.089 and 2.090, 270 
respectively, indicating pure, protein-free samples.  271 
Under basal conditions, T84 cells expressed TLR4 (Figure 6), although this was significantly less than 272 
that of the HT29 cells (*p=0.037).  273 
 274 
  275 
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Discussion 276 
This study has clearly highlighted the potential application for clear, polyester membrane transwell 277 
support systems in the investigation of gastrointestinal pathology. We have shown comparable T84 278 
epithelial cell growth patterns in this model and the traditionally used, gold-standard mixed-cellulose 279 
membranes. T84 cells display normal morphological features when grown on polyester membranes, 280 
with a polarised phenotype complete with apical microvilli and apico-lateral tight junctions. We intend 281 
for this model to be used for side-by-side structural and functional analysis of tight junctions and their 282 
contribution to the development of chemotherapy-induced gastrointestinal dysfunction. 283 
Correspondingly, we have characterised SN38 metabolism in this model, highlighting the metabolic 284 
capabilities of T84 cells. We have also confirmed expression of TLR4, a key mediator of toxicity and 285 
promising target for therapeutic interventions.  286 
Given the inherent challenges in accessing the gastrointestinal tract, a simple in vitro model for 287 
interrogation of complex gastrointestinal physiology is critical in unraveling the mechanisms of 288 
chemotherapy-induced diarrhoea. Characterisation of this model highlights its suitability for the study 289 
for SN38-iduced mucosal damage and the mechanisms and/or implications for tight junction 290 
disruption. Ultrastructurally, these monolayers displayed normal characteristics of the intestinal 291 
epithelium, with a microvillus-studded apical membrane, polarity and typical organelle distribution, 292 
supporting previous phenotype reports (16). Most importantly, intercellular junction complexes were 293 
evident and apical tight junctions appeared phenotypically normal displaying apposing leaflets. 294 
Molecularly, tight junctions of polyester membrane T84 monolayers expressed the key architectural 295 
proteins, ZO-1, claudin-1 and occludin which exhibited typical ‘honeycomb’ or ‘cobblestone’ 296 
distribution.  297 
It is well documented that tight junctions undergo an array of molecular changes in response to 298 
pathological cues (18) with post-translational degradation (19) and redistribution/internalisation of tight 299 
junction proteins reported in response to inflammatory mediators (20-22), kinases (23) and microbiota 300 
changes (24, 25). Internalisation is described most commonly for ZO-1, as it resides in the cytoplasm 301 
adjacent to the plasma membrane of the cell. It has been reported that under pathological states, 302 
particularly those with an inflammatory component, ZO-1 can detach from the junctional complex 303 
leading to altered tight junction integrity and barrier disruption (26). There was no evident 304 
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internalisation of ZO-1, claudin-1 or occludin in T84 monolayers grown in polyester membrane 305 
support systems, indicating that this systems supports molecularly intact, functional tight junctions that 306 
resemble that of the GIT. Furthermore, the transparent properties of the polyester membranes enable 307 
powerful confocal and light microscopy, enhancing the structural analysis of these complex 308 
intercellular structures and allowing paralleled functional and structural analyses. This feature is a 309 
significant advantage of this in vitro model, as structural tight junction analysis is typically achieved by 310 
growing T84 cells on coverslips. The polyester membrane transwell support system therefore provides 311 
a novel platform for interrogation of complex gastrointestinal physiology under normal or challenged 312 
situations and will enable investigation of SN38-induced mucosal damage.  313 
SN38 is the semi-synthetic analogue of the naturally occurring anticancer alkaloid camptothecins and 314 
the active metabolite of irinotecan. The hydroxyl group at the C10 position and ethyl group at the C7 315 
position both help to stabilise SN38 in physiological environments and thus improve its potency (27). 316 
Despite this, SN38 is poorly solubilised and remains relatively unstable in physiological solutions. For 317 
example, the lactone ring of SN38 is stable at pH  4.5 but hydrolyses completely to its carboxylated 318 
form at pH  9. At pH 6.7, both forms are in equilibrium. In our in vitro T84 transwell model, SN38 319 
underwent rapid degradation in physiologically stable cell culture media alone (negative control) 320 
highlighting not only the instability of SN38, but also its relatively short half-life. In the presence of 321 
T84 cells, this degradation was more pronounced, with a further 27.65% reduction from baseline 322 
suggesting T84 cells express the enzymes required for SN38 metabolism (e.g. UGT1A) and further 323 
highlights the suitability of this model for the study of SN38-induced mucosal damage. In addition to 324 
metabolism, our results also showed evidence of SN38 efflux at 48 hours, indicating possible 325 
expression of efflux transporters that utilise SN38 as a substrate in this T84 cell line. ATP binding 326 
cassette (ABC) transporters have been characterised in other human colorectal carcinoma derived cell 327 
lines, such as LS513 (28), but their expression in T84 cells is unclear. The ABC transporter, multidrug 328 
resistance gene 1 (MDR1), as well as and cytochrome P450 isoform 3A4 (CYP3A4), have also been 329 
detected in LS180 cells, whereas only CYP3A4 was inducible in Caco-2 cells and TC-7 cells (29). 330 
Naruhashi and colleagues (2011) have recently shown that mRNA expression the ABC transporters 331 
MDR1, multidrug resistance-associated protein (MRP) 2 and MRP3 is comparable between caco-2 332 
lines and T84 monolayers (30), with minimal differences their pattern of change in response to various 333 
endogenous compounds and xenobiotics. Despite similar expression, the intrinsic function of MDR1 334 
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was stronger in caco-2 cells suggesting caco-2 models are more suitable for the study of drug transport. 335 
Despite this, T84 cells were found to be more sensitive to stimulation by these endogenous 336 
compounds/xenobiotics presumably due to their relatively undifferentiated state relative to caco-2 337 
monolayers. T84 cells therefore present as a superior model for assessing the induction capacity of 338 
compounds and mechanisms of gastrointestinal pathology, whilst caco-2 models are advantageous in 339 
the analysis of drug transport mechanisms and pro-drug development. We also showed that T84 cell 340 
lines express TLR4, whereas the caco-2 cell line did not. Although this largely does not support the 341 
literature, it has been reported that some caco-2 cells will only express TLR4 when stimulated with 342 
LPS (31). In fact, TLR4 expression is comparatively lower in caco-2 cell lines when compared with 343 
numerous other colonic cell lines such as HT29s and T84s (31). This is also the case for TLR4 344 
expression in T84 cells, which in our study was comparatively lower than that seen in HT29 cells. 345 
Nonetheless, the current study has definitively shown that T84 cells express TLR4, thus supporting the 346 
use of this novel in vitro platform for the study of TLR4-targeted interventions for chemotherapy-347 
induced gut toxicity. Development of this in vitro model would therefore not only provide insight into the 348 
mechanisms of SN38-induced mucosal damage, but would also provide an excellent platform in which 349 
to investigate pharmacological strategies critical in the development of effective treatment strategies. 350 
Given the inherent challenges in accessing the gastrointestinal tract, the study of chemotherapy-induced 351 
gut toxicity remains difficult. A simple model for interrogation of complex gastrointestinal physiology 352 
is therefore critical in unraveling the mechanisms of symptoms such as diarrhoea. This study has 353 
successfully demonstrated the use of T84 cells, grown in transparent polyester transwell support 354 
systems, as a suitable model for the study of chemotherapy-induced mucosal damage. This platform 355 
supports a polarised T84 phenotype with functional tight junctions, allowing for in-depth permeability 356 
studies. Additionally, the transparent properties of these inserts allows for sophisticated downstream 357 
analyses such as live-cell fluorescent imaging or confocal microscopy. We also demonstrated that T84 358 
cells exhibit the unique ability to metabolise SN38 as well as expressing TLR4, making this an 359 
excellent platform for the study of clinically relevant therapeutic interventions for SN38-induced 360 
mucosal damage by targeting TLR4.  361 
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Figure legends  471 
Figure 1 (A) Permeable transport support system. This system consists of an inner chamber 472 
allowing the T84 monolayer to be suspended in a supportive media 473 
(DMEMHam’s/F12+1%penicillin/gentamicin+fungizone; 1mM L-glutamine; 10%FBS). (B) Electric 474 
volt ohm-meter. The electrodes of an electric volt ohm-meter pass current and measure voltage to 475 
determine the transepithelial resistance of the monolayer (ohms). For reproducible results, the position 476 
and stability of the electrodes must remain consistent.  477 
Figure 2 Transepithelial resistance (TEER) development over seven days in T84 cells in (A) 478 
mixed cellulose membrane support systems and, (B) polyester membrane support systems. All 479 
seeding densities achieved resistance in both membrane types within seven days. T84 cells seeded at 480 
200,000 cells/cm2 had an elevated trajectory, whilst a seeding density of 50,000 cells/cm2 displayed 481 
delayed maturation and resistance development.   (C) Optimal seeding density appears to be 100,000 482 
cells/cm2 with monolayers showing comparable resistance development in both support systems 483 
(p>0.05). TEER was measured using an EVOM2 epithelial volt-ohm-meter (Physiologic Instruments). 484 
Data expressed as meanSEM and analysed using a one-way analysis of variance with Tukey’s post 485 
hoc.  486 
Figure 3 Transmission electron microscopy images of T84 cells grown on polyester membrane 487 
hanging inserts. Panel A (4200x) shows cellular polarity with apical microvilli (arrow) and a basally-488 
located nucleus (N). Panel B (16500x) shows intercellular junction complexes at the apico-lateral 489 
boundary. Panel C (26500x) shows high power image of the junctional complex; TJ = tight junction, IJ 490 
= intermediate junction, D = desmosome.  491 
Figure 4 Immunofluorescent staining of (A) ZO-1 (red), (B) occludin (green) and (C) claudin-1 492 
(cyan) in T84 monolayers. The border of each cell can be distinguished by immunocytochemical 493 
circumferential staining of each tight junction protein. T84 monolayers were fixed in 1:1 (v/v) 494 
acetone/methanol, before being permeabilised with 0.1% TritonX-100. Cells were blocked with 3% 495 
BSA before the primary antibodies for ZO-1, occludin and claudin-1 were applied. Monolayers were 496 
then incubated with fluorescently-conjugated secondary anti-rabbit/mouse antibodies at 568 nm and 497 
488 nm, respectively. Panel C has been pseudocoloured cyan for this figure. (D) XZ image showing 498 
occludin staining (arrow) at the cell periphery. The composite XZ stack shows apically located 499 
occludin staining which ceases toward the basal surface of the cell. The XZ composite was generated 500 
from 30 x 1 μm z-sections using the public domain Java image processing programme, Image J.  501 
Figure 5 SN38 concentration in transwell support systemT84 monolayers. Data presented as (A) 502 
concentration (nM) or, (B) relative to baseline (%). Transwell support systemsT84 monolayers were 503 
treated with 5 M SN38. The apical and basolateral chambers were sampled at 1 h, 3 h, 6 h, 24 h and 504 
48 h. SN38 concentration was determined by liquid chromatography–mass spectrometry (ABSCIEX 505 
TripleTOFTM  5600 LC/MS/MS). SN38 underwent rapid degradation in cell culture media, with a 506 
48.394.01% decrease from baseline by 1 h. Degradation is more pronounced in transwell supports 507 
508 
SN38 can be seen at 48 h, with a spike in concentration. This is only observed in the presence of T84 509 
monolayers. 510 
Figure 6 TLR4 mRNA expression in T84 and HT29 cells relative to internal housekeeping gene 511 
-actin. Relative expression was determined using the CT method. Expression of TLR4 in Caco-2 512 
cells was below detectable levels. Data expressed as meanSEM. A one-way analysis of variance with 513 
Tukey’s post hoc was performed to dertermine statistical significance.  514 
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